{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32796875", "DateCompleted": {"Year": "2021", "Month": "02", "Day": "09"}, "DateRevised": {"Year": "2022", "Month": "01", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "08", "Day": "14"}], "Language": ["eng"], "ELocationID": ["13804", "10.1038/s41598-020-70493-1"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "10", "Issue": "1", "PubDate": {"Year": "2020", "Month": "Aug", "Day": "14"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Identification and characterization of plant-derived alkaloids, corydine and corydaline, as novel mu opioid receptor agonists.", "Pagination": {"StartPage": "13804", "MedlinePgn": "13804"}, "Abstract": {"AbstractText": ["Pain remains a key therapeutic area with intensive efforts directed toward finding effective and safer analgesics in light of the ongoing opioid crisis. Amongst the neurotransmitter systems involved in pain perception and modulation, the mu-opioid receptor (MOR), a G protein-coupled receptor, represents one of the most important targets for achieving effective pain relief. Most clinically used opioid analgesics are agonists to the MOR, but they can also cause severe side effects. Medicinal plants represent important sources of new drug candidates, with morphine and its semisynthetic analogues as well-known examples as analgesic drugs. In this study, combining in silico (pharmacophore-based virtual screening and docking) and pharmacological (in vitro binding and functional assays, and behavioral tests) approaches, we report on the discovery of two naturally occurring plant alkaloids, corydine and corydaline, as new MOR agonists that produce antinociceptive effects in mice after subcutaneous administration via a MOR-dependent mechanism. Furthermore, corydine and corydaline were identified as G protein-biased agonists to the MOR without inducing \u03b2-arrestin2 recruitment upon receptor activation. Thus, these new scaffolds represent valuable starting points for future chemical optimization towards the development of novel opioid analgesics, which may exhibit improved therapeutic profiles."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Institute of Pharmacy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria."}], "LastName": "Kaserer", "ForeName": "Teresa", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Institute of Pharmacy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria."}], "LastName": "Steinacher", "ForeName": "Theresa", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Institute of Pharmacy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria."}], "LastName": "Kainhofer", "ForeName": "Roman", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Institute of Pharmacy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria."}], "LastName": "Erli", "ForeName": "Filippo", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Institute of Pharmacy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria."}], "LastName": "Sturm", "ForeName": "Sonja", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Institute of Pharmacy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria. Birgit.Waltenberger@uibk.ac.at."}], "LastName": "Waltenberger", "ForeName": "Birgit", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Institute of Pharmacy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria. Daniela.Schuster@pmu.ac.at."}, {"Identifier": [], "Affiliation": "Department of Medicinal and Pharmaceutical Chemistry, Institute of Pharmacy, Paracelsus Medical University, Strubergasse 22, 5020, Salzburg, Austria. Daniela.Schuster@pmu.ac.at."}], "LastName": "Schuster", "ForeName": "Daniela", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Institute of Pharmacy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria. Mariana.Spetea@uibk.ac.at."}], "LastName": "Spetea", "ForeName": "Mariana", "Initials": "M"}], "GrantList": [{"GrantID": "I 2463", "Acronym": "FWF_", "Agency": "Austrian Science Fund FWF", "Country": "Austria"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Analgesics"}, {"RegistryNumber": "0", "NameOfSubstance": "Aporphines"}, {"RegistryNumber": "0", "NameOfSubstance": "Berberine Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Opioid, mu"}, {"RegistryNumber": "08N392L8VX", "NameOfSubstance": "corydaline"}, {"RegistryNumber": "476-69-7", "NameOfSubstance": "corydine"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Alkaloids"}, {"QualifierName": [], "DescriptorName": "Analgesics"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Aporphines"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Berberine Alkaloids"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": [], "DescriptorName": "Cricetulus"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Molecular Targeted Therapy"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Pain"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["agonists"], "DescriptorName": "Receptors, Opioid, mu"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Devereaux AL, Mercer SL, Cunningham CW. DARK classics in chemical neuroscience: Morphine. ACS Chem. Neurosci. 2018;9:2395\u20132407.", "ArticleIdList": ["29757600"]}, {"Citation": "F\u00fcrst S, Hosztafi S. The chemical and pharmacological importance of morphine analogues. Acta Physiol. Hung. 2008;95:3\u201344.", "ArticleIdList": ["18389996"]}, {"Citation": "Spetea M, Asim MF, Wolber G, Schmidhammer H. The \u00b5 opioid receptor and ligands acting at the \u00b5 opioid receptor, as therapeutics and potential therapeutics. Curr. Pharm. Des. 2013;19:7415\u20137434.", "ArticleIdList": ["23448479"]}, {"Citation": "Armenian P, et al. Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review. Neuropharmacology. 2018;134:121\u2013213.", "ArticleIdList": ["29042317"]}, {"Citation": "Pasternak GW, et al. Emerging insights into mu opioid pharmacology. Handb. Exp. Pharmacol. 2020;258:89\u2013125.", "ArticleIdList": ["31598835"]}, {"Citation": "Benyamin R, et al. Opioid complications and side effects. Pain Physician. 2008;11:S105\u2013S120.", "ArticleIdList": ["18443635"]}, {"Citation": "Seth P, Scholl L, Rudd RA, Bacon S. Overdose deaths involving opioids, cocaine, and psychostimulants\u2014United States, 2015\u20132016. MMWR Morb. Mortal. Wkly. Rep. 2018;67:349\u2013358.", "ArticleIdList": ["PMC5877356", "29596405"]}, {"Citation": "Volkow ND, Jones EB, Einstein EB, Wargo EM. Prevention and treatment of opioid misuse and addiction: A review. JAMA Psychiatry. 2019;76:208\u2013216.", "ArticleIdList": ["30516809"]}, {"Citation": "Baumann MH, et al. Pharmacological research as a key component in mitigating the opioid overdose crisis. Trends Pharmacol. Sci. 2018;39:995\u2013998.", "ArticleIdList": ["30454770"]}, {"Citation": "Skolnick P. The opioid epidemic: Crisis and solutions. Annu. Rev. Pharmacol. Toxicol. 2018;58:143\u2013159.", "ArticleIdList": ["28968188"]}, {"Citation": "Ehrlich AT, Kieffer BL, Darcq E. Current strategies toward safer mu opioid receptor drugs for pain management. Expert Opin. Ther. Targets. 2019;23:315\u2013326.", "ArticleIdList": ["PMC6497449", "30802415"]}, {"Citation": "Turnaturi R, et al. Progress in the development of more effective and safer analgesics for pain management. Eur. J. Med. Chem. 2019;183:111701.", "ArticleIdList": ["31550662"]}, {"Citation": "Stein C. Opioid receptors. Ann. Rev. Med. 2016;67:433\u2013451.", "ArticleIdList": ["26332001"]}, {"Citation": "Corder G, et al. Endogenous and exogenous opioids in pain. Annu. Rev. Neurosci. 2018;41:453\u2013473.", "ArticleIdList": ["PMC6428583", "29852083"]}, {"Citation": "Manglik A, et al. Crystal structure of the mu-opioid receptor bound to a morphinan antagonist. Nature. 2012;485:321\u2013326.", "ArticleIdList": ["PMC3523197", "22437502"]}, {"Citation": "Huang W, et al. Structural Insights into \u03bc-opioid receptor activation. Nature. 2015;524:315\u2013321.", "ArticleIdList": ["PMC4639397", "26245379"]}, {"Citation": "Koehl A, et al. Structure of the \u00b5-opioid receptor\u2013Gi protein complex. Nature. 2018;558:547\u2013552.", "ArticleIdList": ["PMC6317904", "29899455"]}, {"Citation": "Grim TW, Acevedo-Canabal A, Bohn LM. Toward directing opioid receptor signaling to refine opioid therapeutics. Biol. Psychiatry. 2020;87:15\u201321.", "ArticleIdList": ["PMC6919561", "31806082"]}, {"Citation": "Valentino RJ, Volkow ND. Untangling the complexity of opioid receptor function. Neuropsychopharmacology. 2018;43:2514\u20132520.", "ArticleIdList": ["PMC6224460", "30250308"]}, {"Citation": "Li JW, Vederas JC. Drug discovery and natural products: End of an era or an endless frontier? Science. 2009;325:161\u2013165.", "ArticleIdList": ["19589993"]}, {"Citation": "Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J. Nat. Prod. 2020;83:770\u2013803.", "ArticleIdList": ["32162523"]}, {"Citation": "Kruegel AC, et al. Synthetic and receptor signaling explorations of the Mitragyna alkaloids: Mitragynine as an atypical molecular framework for opioid receptor modulators. J. Am. Chem. Soc. 2016;138:6754\u20136764.", "ArticleIdList": ["PMC5189718", "27192616"]}, {"Citation": "Kruegel AC, Grundmann O. The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse. Neuropharmacology. 2018;134:108\u2013120.", "ArticleIdList": ["28830758"]}, {"Citation": "Kruegel AC, et al. 7-Hydroxymitragynine is an active metabolite of mitragynine and a key mediator of its analgesic effects. ACS Cent. Sci. 2019;5:992\u20131001.", "ArticleIdList": ["PMC6598159", "31263758"]}, {"Citation": "Cui X, et al. Ligand interaction, binding site and G protein activation of the mu opioid receptor. Eur. J. Pharmacol. 2013;702:309\u2013315.", "ArticleIdList": ["PMC3608745", "23415745"]}, {"Citation": "Kaserer T, Lantero A, Schmidhammer H, Spetea M, Schuster D. \u03bc Opioid receptor: Novel antagonists and structural modeling. Sci. Rep. 2016;6:21548.", "ArticleIdList": ["PMC4757823", "26888328"]}, {"Citation": "Manglik A, et al. Structure-based discovery of opioid analgesics with reduced side effects. Nature. 2016;537:185\u2013190.", "ArticleIdList": ["PMC5161585", "27533032"]}, {"Citation": "Noha SM, et al. Molecular docking, molecular dynamics, and structure-activity relationship explorations of 14-oxygenated N-methylmorphinan-6-ones as potent \u03bc-opioid receptor agonists. ACS Chem. Neurosci. 2017;8:1327\u20131337.", "ArticleIdList": ["PMC5481819", "28125215"]}, {"Citation": "Sutcliffe KJ, et al. Drug binding poses relate structure with efficacy in the \u03bc opioid receptor. J. Mol. Biol. 2017;429:1840\u20131851.", "ArticleIdList": ["PMC5472181", "28502792"]}, {"Citation": "Wtorek K, et al. Endomorphin-2 analogs containing modified tyrosines: Biological and theoretical investigation of the influence on conformation and pharmacological profile. Eur. J. Med. Chem. 2019;179:527\u2013536.", "ArticleIdList": ["31276897"]}, {"Citation": "Obeng S, et al. Structure-activity relationship studies of 6\u03b1- and 6\u03b2-indolylacetamidonaltrexamine derivatives as bitopic mu opioid receptor modulators and elaboration of the \u201cmessage-address concept\u201d to comprehend their functional conversion. ACS Chem. Neurosci. 2019;10:1075\u20131090.", "ArticleIdList": ["PMC6405326", "30156823"]}, {"Citation": "Ellis CR, et al. Evaluating kratom alkaloids using PHASE. PLoS ONE. 2020;15:e0229646.", "ArticleIdList": ["PMC7053747", "32126112"]}, {"Citation": "Surratt CK, et al. Mu opiate receptor Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. J. Biol. Chem. 1994;269:20548\u201320553.", "ArticleIdList": ["8051154"]}, {"Citation": "Mansour A, et al. Key residues defining the \u03bc-opioid receptor binding pocket: A site-directed mutagenesis study. J. Neurochem. 1997;68:344\u2013353.", "ArticleIdList": ["8978745"]}, {"Citation": "Reiter E, et al. Molecular mechanism of \u03b2-arrestin-biased agonism at seven-transmembrane receptors. Annu. Rev. Pharmacol. Toxicol. 2012;52:179\u2013197.", "ArticleIdList": ["PMC3628752", "21942629"]}, {"Citation": "Zhou L, Bohn LM. Functional selectivity of GPCR signaling in animals. Curr. Opin. Chem. Biol. 2014;27:102\u2013108.", "ArticleIdList": ["PMC4349326", "24680435"]}, {"Citation": "DeWire SM, et al. A G protein-biased ligand at the \u03bc-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine. J. Pharmacol. Exp. Ther. 2013;344:708\u2013717.", "ArticleIdList": ["23300227"]}, {"Citation": "V\u00e1radi A, et al. Mitragynine/corynantheidine pseudoindoxyls as opioid analgesics with mu agonism and delta antagonism, which do not recruit \u03b2-arrestin-2. J. Med. Chem. 2016;59:8381\u20138839.", "ArticleIdList": ["PMC5344672", "27556704"]}, {"Citation": "Schmid CL, et al. Bias factor and therapeutic window correlate to predict safer opioid analgesics. Cell. 2017;171:1165\u20131175.", "ArticleIdList": ["PMC5731250", "29149605"]}, {"Citation": "Martin C, et al. Biodegradable amphipathic peptide hydrogels as extended-release system for opioid peptides. J. Med. Chem. 2018;61:9784\u20139789.", "ArticleIdList": ["30351003"]}, {"Citation": "Kenakin T, Christopoulos A. Signaling bias in new drug discovery: Detection, quentification and therapeutic impact. Nat. Rev. Drug Discov. 2013;12:205\u2013216.", "ArticleIdList": ["23411724"]}, {"Citation": "Le Bars D, et al. Animal models of nociception. Pharmacol. Rev. 2001;53:597\u2013652.", "ArticleIdList": ["11734620"]}, {"Citation": "Schr\u00f6dinger Release 2019\u20134: Maestro, Schr\u00f6dinger, LLC, New York, NY, 2019."}, {"Citation": "Keiser MJ, et al. Relating protein pharmacology by ligand chemistry. Nat. Biotech. 2007;25:197\u2013206.", "ArticleIdList": ["17287757"]}, {"Citation": "Ma Z-Z, et al. Isoquinoline alkaloids isolated from Corydalis yanhusuo and their binding affinities at the dopamine D1 receptor. Molecules. 2008;13:2303\u20132312.", "ArticleIdList": ["PMC6245449", "18830156"]}, {"Citation": "Wu L, et al. Identification of alkaloids from Corydalis yanhusuo W.T. Wang as dopamine D1 receptor antagonists by using CRE-luciferase reporter gene assay. Molecules. 2018;23:2585.", "ArticleIdList": ["PMC6222624", "30308941"]}, {"Citation": "Ji HY, et al. In vitro metabolism of corydaline in human liver microsomes and hepatocytes using liquid chromatography-ion trap mass spectrometry. J. Sep. Sci. 2012;35:1102\u20131109.", "ArticleIdList": ["22689485"]}, {"Citation": "Rankovic Z, et al. Biased agonism: An emerging paradigm in GPCR drug discovery. Bioorg. Med. Chem. Lett. 2016;26:241\u2013250.", "ArticleIdList": ["PMC5595354", "26707396"]}, {"Citation": "McClatchey WC, et al. Ethnobotany as a pharmacological research tool and recent developments in CNS-active natural products from ethnobotanical sources. Pharmacol. Ther. 2009;123:239\u2013254.", "ArticleIdList": ["PMC2700180", "19422851"]}, {"Citation": "Prevatt-Smith KM, Prisinzano TE. New therapeutic potential for psychoactive natural products. Nat. Prod. Rep. 2010;27:23\u201331.", "ArticleIdList": ["20024092"]}, {"Citation": "Di Marzo V. Endocannabinoids: Synthesis and degradation. Rev. Physiol. Biochem. Pharmacol. 2008;160:1\u201324.", "ArticleIdList": ["18481028"]}, {"Citation": "Bermudez M, et al. Strategies for the discovery of biased GPCR ligands. Drug Discov. Today. 2019;24:1031\u20131037.", "ArticleIdList": ["30831262"]}, {"Citation": "Scior T, et al. Recognizing pitfalls in virtual screening: A critical review. J. Chem. Inf. Model. 2012;52:867\u2013881.", "ArticleIdList": ["22435959"]}, {"Citation": "Dumitrascuta M, Bermudez M, Ballet S, Wolber G, Spetea M. Mechanistic understanding of peptide analogues, DALDA, [Dmt1]DALDA, and KGOP01, binding to the mu opioid receptor. Molecules. 2020;25:2087.", "ArticleIdList": ["PMC7248707", "32365707"]}, {"Citation": "Karimov A, et al. Berberis alkaloids. XXIII. Structure of turcberine. Khim Prirodn Soedin. 1993;1:77\u201381."}, {"Citation": "Adsersen A, et al. Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Corydalis cava Schweigg. & Kort. J. Ethnopharmacol. 2007;113:179\u2013182.", "ArticleIdList": ["17574358"]}, {"Citation": "Wang X, et al. Preparative isolation of alkaloids from Dactylicapnos scandens using pH-zone-refining counter-current chromatography by changing the length of the separation column. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2011;879:3767\u20133770.", "ArticleIdList": ["22056347"]}, {"Citation": "Han JW, et al. In vivo disease control efficacy of isoquinoline alkaloids isolated from Corydalis ternata against wheat leaf rust and pepper anthracnose. J. Microbiol. Biotechnol. 2018;28:262\u2013266.", "ArticleIdList": ["29141127"]}, {"Citation": "Wang C, et al. Screening of antinociceptive components in Corydalis yanhusuo W.T. Wang by comprehensive two-dimensional liquid chromatography/tandem mass spectrometry. Anal. Bioanal. Chem. 2010;396:1731\u20131740.", "ArticleIdList": ["20101504"]}, {"Citation": "Ruiz A, et al. Flavonols, alkaloids, and antioxidant capacity of edible wild berberis species from Patagonia. J. Agric. Food Chem. 2014;62:12407\u201312417.", "ArticleIdList": ["25495577"]}, {"Citation": "Wang JB, Mantsch JR. l-Tetrahydropalamatine: A potential new medication for the treatment of cocaine addiction. Future Med. Chem. 2012;4:177\u2013186.", "ArticleIdList": ["PMC3878639", "22300097"]}, {"Citation": "China Pharmacopoeia Committee. Pharmacopoeia of People's Republic of China, China Chemical Industry Press, second ed. (2005)."}, {"Citation": "Blumenthal, M., Busse, W.R., Goldbert, A., Gruenwald, J., Hall, T., Klein, S., Riggins, C.W. & Rister, R.S. The complete German E monographs-therapeutic guide to herbal medicines. American Botanical Council, Austin, TX, p. 310 (1998)."}, {"Citation": "Sezik E, et al. Traditional medicine in Turkey II. Folk medicine in Kastamonu. Int. J. Pharmacog. 1992;30:233\u2013239."}, {"Citation": "Chang H-J, et al. Study on chemical constituents of Dicranostigma leptopodium (Maxim.) Fedde. Yaoxue Tongbao. 1981;16:52."}, {"Citation": "Qiu ZC, et al. Comparative study between Rhizoma Corydalis processing with vinegar and cleansing Rhizoma Corydalis in anti-inflammatory effect and analgesic effect. Prog. Mod. Biomed. 2009;9:4518\u20134521."}, {"Citation": "Li R, Niu Y-B, Dou Z-Y. Comparative study for pharmacological action of Corydalis Rhizoma before and after processing. Chin. Herb. Med. 2015;7:247\u2013254."}, {"Citation": "Tang W, Eisenbrand G. Chinese drugs of plant origin: Chemistry, pharmacology, and use in traditional and modern medicine. Berlin: Springer; 1992. pp. 377\u2013393."}, {"Citation": "Wang J, et al. Preclinical pharmacokinetics, tissue distribution and excretion studies of a potential analgesics\u2014corydaline using an ultra performance liquid chromatography-tandem mass spectrometry. J.. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2013;30:942\u2013943.", "ArticleIdList": ["24216274"]}, {"Citation": "OMEGA 2.5.1.4: OpenEye Scientific Software, Santa Fe, NM. https://www.eyesopen.com/"}, {"Citation": "Hawkins PCD, et al. Conformer generation with OMEGA: Algorithm and validation using high quality structures from the protein databank and cambridge structural database. J. Chem. Inf. Model. 2010;50:572\u2013584.", "ArticleIdList": ["PMC2859685", "20235588"]}, {"Citation": "Wolber G, Langer T. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J. Chem. Inf. Model. 2005;45:160\u2013169.", "ArticleIdList": ["15667141"]}, {"Citation": "Inte:Ligand GmbH (2015). LigandScout 3.1. Vienna: Inte:Ligand GmbH."}, {"Citation": "Madhavi Sastry G, et al. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J. Comput. Aided Mol. Des. 2013;27:221\u2013234.", "ArticleIdList": ["23579614"]}, {"Citation": "de Bruyn Kops C, Stork C, \u0160\u00edcho M, Kochev N, Svozil D, Jeliazkova N, Kirchmair J. GLORY: generator of the Structures of likely cytochrome P450 metabolites based on predicted sites of metabolism. Front. Chem. 2019;7:402.", "ArticleIdList": ["PMC6582643", "31249827"]}, {"Citation": "Sturm S, et al. Analysis of central European Corydalis species by nonaqueous capillary electrophoresis\u2014electrospray ion trap mass spectrometry. J. Chromatogr. A. 2007;1159:41\u201350.", "ArticleIdList": ["17395190"]}, {"Citation": "Bradford MM. A Rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976;72:248\u2013254.", "ArticleIdList": ["942051"]}, {"Citation": "Cheng Y, Prusoff WH. Relationship between the inhibition constant (k1) and the concentration of inhibitor which causes 50 per cent inhibition (i50) of an enzymatic reaction. Biochem. Pharmacol. 1973;22:3099\u20133108.", "ArticleIdList": ["4202581"]}]}], "History": [{"Year": "2020", "Month": "6", "Day": "10"}, {"Year": "2020", "Month": "7", "Day": "27"}, {"Year": "2020", "Month": "8", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "2", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "14"}], "PublicationStatus": "epublish", "ArticleIdList": ["32796875", "PMC7427800", "10.1038/s41598-020-70493-1", "10.1038/s41598-020-70493-1"]}}]}